ArticleJournal of global health2026
Editor's view: What makes a scientist successful?
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This editorial examines the nature of scientific discovery by studying the characteristics, methods, and tools that have historically defined a 'successful scientist'. It first considers the traditional hypothesis-driven model of science founded on existing knowledge, testable hypotheses, and experiments based on precise measurements. Through illustrative examples, it distinguishes three types of highly successful scientific contributors: those who formulated novel hypotheses and theories that proved groundbreaking, those who developed transformative measurement tools that enabled experimental testing, and those who managed to do both, even in multiple scientific fields. While success has historically depended on access to knowledge, exceptional creativity, perseverance, and experimental rigor, this editorial reminds that serendipity and timing have also played important roles. It also points to the limits of science when hypotheses remain untestable and theories unfalsifiable. It then reviews modern developments that challenge traditional approaches, such as genome-wide association studies (GWAS), where clear and specific hypotheses are no longer a prerequisite for important novel discoveries, and where discovery can emerge from data mining, rather than from pre-existing knowledge and creative hypothesis. The editorial then progresses onto the emergence of machine-led scientific discovery, using the example of the DeepMind team's development of AlphaFold - an artificial intelligence (AI) system that accurately predicted protein folding without relying on traditional hypotheses. AlphaFold learned directly from data and revolutionised the entire field of structural biology, bringing a new era of machine-inferred and AI-based science. The described frameworks are then used to analyse the development of an emerging field of science, 'ideometrics', based on the theory of the brain's 'sense of ideas', explaining how it could potentially contribute to understanding the purpose of consciousness as a complex trait in evolutionary terms. Being conscious provides an advantage by enabling the brain's 'sense of ideas' to reduce informational entropy of all possible future states of a conscious being to a narrower range of the outcomes that are perceived as more favourable for its survival. Perception of time and space in humans is, therefore, intertwined with their conscious 'sense of ideas', both while awake and dreaming, and further research in neuroscience will be required to elucidate these relationships. In conclusion, the editorial offers a comprehensive reflection on how the definition of a 'successful scientist' is being substantially reshaped in the 21st century.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.